查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1819974

腸躁症治療市場報告（按類型（腹瀉型腸躁症、便秘型腸躁症、混合型腸躁症）、產品、配銷通路和地區分類，2025 年至 2033 年）

Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea, IBS with Constipation, Mixed IBS), Product, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球腸躁症治療市場規模達 29 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 57 億美元，2025-2033 年期間的成長率 (CAGR) 為 7.8%。

腸躁症 (IBS) 是一種影響大腸的慢性疾病。它通常由嚴重感染、緊張的生活方式、腸道菌群變化、腸道肌肉收縮以及神經系統異常引起。其症狀包括脹氣、腹瀉、痙攣、腹脹、便秘、體重減輕、嘔吐、腹痛和吞嚥困難。目前有幾種藥物可用於緩解 IBS 的輕微症狀，包括利福昔明、洛哌丁胺、瀉藥、解痙藥、膳食纖維補充劑和薄荷油膠囊。醫生也建議某些患者使用益生菌和心理健康療法，例如認知行為療法 (CBT)、腸道催眠療法和放鬆訓練。

腸躁症治療市場趨勢：

多種因素會增加腸躁症 (IBS) 的風險，包括食物不耐受或敏感、消化道細菌感染、小腸細菌過度生長以及焦慮、憂鬱和身體症狀等精神障礙。此外，診斷方法的改善和醫療服務的便捷獲取，是推動市場成長的關鍵因素之一。此外，IBS 是老年人中最常見的功能性胃腸病之一。同時，全球老年人口的成長也對市場產生了正面影響。此外，一些臨床試驗正在進行中，例如糞便微生物移植 (FMT)，旨在改善 IBS 的治療，這也有助於市場成長。除此之外，作為永續發展目標（SDG）的一部分，各國管理機構已承諾在2030年大幅增加研發（R&D）計畫的支出和研究人員的數量。這反過來預計會擴大未來IBS的潛在治療選擇的數量。

本報告回答的關鍵問題：

  • 全球腸躁症治療市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球腸躁症治療市場有何影響？
  • 主要的區域市場有哪些？
  • 根據類型，市場是如何分類的？
  • 根據產品，市場是如何分類的？
  • 根據配銷通路，市場是如何分類的？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球腸躁症治療市場的結構是怎麼樣的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球腸躁症治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 腹瀉型腸躁症 (IBS-D)
  • 伴隨便秘的腸躁症 (IBS-C)
  • 混合性腸躁症

第7章：市場區隔：依產品

  • 利福昔明
  • 艾盧沙多林
  • 魯比前列酮
  • 利那洛肽
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 藥局和零售藥房
  • 網路商店

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Allergan plc (AbbVie Inc.)
    • Ardelyx Inc.
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bausch Health Companies Inc.
    • GlaxoSmithKline Plc
    • Novartis AG
    • Sebela Pharmaceuticals Inc.
    • Synthetic Biologics Inc.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A4297

The global irritable bowel syndrome treatment market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.8% during 2025-2033.

Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients.

Irritable Bowel Syndrome Treatment Market Trends:

Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.

Key Market Segmentation:

Breakup by Type:

  • IBS with Diarrhea (IBS-D)
  • IBS with Constipation (IBS-C)
  • Mixed IBS

Breakup by Product:

  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Linaclotide
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Stores

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report:

  • How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Irritable Bowel Syndrome Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 IBS with Diarrhea (IBS-D)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 IBS with Constipation (IBS-C)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Mixed IBS
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Rifaximin
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Eluxadoline
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Lubiprostone
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Linaclotide
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Stores and Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Allergan plc (AbbVie Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ardelyx Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 AstraZeneca plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Bausch Health Companies Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GlaxoSmithKline Plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sebela Pharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthetic Biologics Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
  • Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
  • Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
  • Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players